News & ViewsNewslettersContactBecome a Research Patient
DHRHealth Institute for Research and Development

Clinical Trial

A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)

Study Status:

Open For Enrollment

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

The primary objective of this study is to test an investigational product, HTD1801 and evaluate the effects on liver fat content (LFC) in adults between 18 and 75 years of age who have been diagnosed with T2DM and nonalcoholic steatohepatitis, also known as NASH.

Information: 

Principal Investigator
Rashmee Patil, MD
Sponsor
HighTide Biopharma Pty Ltd
Type of Trial
Randomized, Controlled, Single-Blinded
DHRHealth Institute for Research and Development
5323 S. McColl Rd., Edinburg, TX 78539
(956) 362-2390
© 2022 DHR Health Institute for Research & Development | All Rights Reserved | Terms & Conditions | Site By: KangoMedia
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram